Teladoc Health Launches “myStrength Complete” As First Unified Mental Health Care Experience

Teladoc Health, Inc. (NYSE: TDOC) today announced the launch of myStrength Complete, an integrated mental health service providing personalized, targeted care to consumers in a single, comprehensive experience.

The announcement comes as more than half of people with mental health concerns report that they do not know where to start when getting care, highlighting the importance of the digital front door myStrength Complete will provide.

A new consumer study released by Teladoc Health also revealed individuals’ openness to using a broad range of new and traditional mental health services in the midst of the ongoing mental health crisis, giving nearly identical high ratings to their virtual and in-person mental health care experiences, while also expressing a strong desire to have the single unified experience promised by myStrength Complete. Some 69 percent of people surveyed who sought support indicated it would be difficult and/or overwhelming to use multiple websites, mobile apps or virtual care platforms to address mental health needs. myStrength Complete’s proprietary stepped care model is designed to seamlessly combine app-based tools and coaching expertise with Teladoc’s therapists and psychiatrists to ensure that consumers get the level of mental health support and care they need, when they need it.

“We are connecting the full range of mental health services from apps to clinicians so that people can access timely help, tailored to their needs and on their terms,” said David Sides, chief operating officer at Teladoc Health. “myStrength Complete meets the dual consumer needs of comprehensive mental health care and a simplified experience in one service – developed through the integration of Teladoc Health and Livongo.”

Today’s findings also demonstrated the efficacy of virtual mental health care during the current mental health crisis, which has been exacerbated by the combination of health, economic and social challenges facing the country. Nearly all of those surveyed who said they sought virtual mental health support – 92 percent – reported at least some improvement during the pandemic, with over one-third reporting significant improvement or a “breakthrough” during treatment. Of those who leveraged virtual mental healthcare, 47 percent used the service at least weekly.

“Mental health needs and utilization rates have grown dramatically since the pandemic began, paving the way for a new mental healthcare consumer – one who embraces virtual-first and digital channels for support,” said Dr. Julia Hoffman, head of clinical strategy, mental health for Teladoc Health. “Virtual mental healthcare is no longer just a benefit for employees, it is a necessity.”

myStrength Complete will be available to consumers through their health plans or employers in July, with pre-announcement sales already ensuring hundreds of thousands of consumers will have access to the new service this summer. Initial buyers of myStrength Complete currently include a major Blues plan and a Fortune 100 employer. More than eight in ten consumers who sought support now say they are comfortable using mental health resources through their employer, in a marked shift away from historical concerns with workplace stigma.

The consumer study released today was conducted on behalf of Teladoc Health by TRC Market Research. Respondents included 2,253 U.S. consumers surveyed online between April 8 and 20, 2021. Survey here.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.